A. Hinton Johnson
Corporate Compliance Officer and Assistant SecretarySeaboard
Fortune 500View Profile →Senior Vice President, Quality, Regulatory & Patient Safety · Baxter International
Scott Kaplan is Baxter’s senior vice president for Quality, Regulatory and Patient Safety. He is a former FDA attorney and law-firm partner who joined Baxter’s legal team in 2024.
Last reviewed: Nov 2, 2026
Senior Vice President, Quality, Regulatory & Patient Safety
Baxter International
Last Reviewed: November 2, 2026
Scott Kaplan is Baxter’s senior vice president for Quality, Regulatory and Patient Safety. He is a former FDA attorney and law-firm partner who joined Baxter’s legal team in 2024.
Kaplan joined Baxter in 2024 as deputy general counsel for Regulatory Law. In 2026, he moved into leadership of the company’s global Quality, Regulatory Affairs and Patient Safety organization.
Before joining Baxter, Kaplan practiced at Sidley Austin and Hogan Lovells, where he became a partner. His work focused on regulatory requirements affecting pharmaceutical, biotechnology and medical-device businesses. Earlier, as associate chief counsel for Enforcement in the U.S. Food and Drug Administration’s Office of the Chief Counsel, he worked on matters involving seizures, injunctions, administrative detention and criminal prosecutions.
His professional education activities have included teaching manufacturing regulation for the Food and Drug Law Institute. The institute’s August 2020 program listed him as counsel at Hogan Lovells, co-presenting a session on that topic. His speaker biography described work preparing clients for inspections and responding to FDA observations, warning letters and other enforcement actions, as well as advice concerning data integrity and the Drug Supply Chain Security Act.
After moving in-house, Kaplan participated in Sidley’s May 2024 Boston Life Sciences Roundtable as Baxter’s deputy general counsel. That session addressed current healthcare and FDA trends for life-sciences companies.
Kaplan earned a Juris Doctor from the University of Pennsylvania Carey Law School and a master’s degree in bioethics from Penn’s Perelman School of Medicine.